Journal of Health Sciences & Research

Register      Login

VOLUME 10 , ISSUE 2 ( July-December, 2019 ) > List of Articles

REVIEW ARTICLE

Probiotics and Oral Malodor

Nitish Bhat, Nandini Bhardwaj, Abhiney Puri, Rajat Nangia

Citation Information : Bhat N, Bhardwaj N, Puri A, Nangia R. Probiotics and Oral Malodor. J Health Sci Res 2019; 10 (2):31-34.

DOI: 10.5005/jp-journals-10042-1078

License: CC BY-NC 4.0

Published Online: 03-11-2020

Copyright Statement:  Copyright © 2019; The Author(s).


Abstract

The efficacy of probiotics or the viable bacteria specifically in the oral cavity with proven health benefits acts as a natural approach against the naturally developing microbiome imbalance and is enormously popular worldwide. To put a stop to oral diseases, probiotics bring to us an imperative concept of biological changes in microbial flora. Various clinical studies reveal the reduction in the concentration of bacteria causing dental caries, halitosis, and periodontitis. The prevention and control of oral malodor or halitosis is spotlighted as it unswervingly affects the communal life in polygenic unfavorable ways. This paper evaluates the present acquaintance, etiology, verdict, and promising management approaches for oral malodor with probiotics.


HTML PDF Share
  1. Scully C, Greenman J. Halitosis (bad breath). Periodontology 2000 2008;48:67–75. DOI: 10.1111/j.1600-0757.2008.00266.x.
  2. Pratibha PK, Bhat KM, Bhat GS. Oral malodor: a review of literature. J Dental Hyg. 2006;80(3):8.
  3. Touyz LZ. Oral malodor: a review. J Can Dent Assoc 1993;59(7): 607–610.
  4. Bicak DA. A current approach to halitosis & oral malodor – a mini review. open Dent J. 2018;12:322–330. DOI: 10.2174/1874210601812010322.
  5. Akaji Ezi A, Folarmani N, Ashiwaju O. Halitosis: a review of literature on its prevalence, impact & control. Oral Health Prev Dent 2014;12(4): 297–304. DOI: 10.3290/j.ohpd.a33135.
  6. Goldberg S, Kozlovsky A, Gordon D, et al. Cadaverine as a putative component of oral malodor. J Dent Res 1994;73(6):1168–1172. DOI: 10.1177/00220345940730060701.
  7. Martinez RCR, Bedani R, Saad SMI. Scientific evidence for health effects attributed to the consumption of probiotics & prebiotics: an update for current perspectives & future challenges. Br J Nutr 2015;114(12):1993–2015. DOI: 10.1017/S0007114515003864.
  8. Zahir S, Bose S, Chaudhury UR. Probiotics and its role in dental caries. Science and Culture 2011;77(11–12):507–510.
  9. Sterer N, Bar-Ness Greenstein R, Rosenberg M. β-Galactosidase activity in saliva is associated with oral malodor. J Dent Res 2002;81(3):182–185. DOI: 10.1177/0810182.
  10. Koshimune S, Awano S, Gohara K, et al. Low salivary flow and volatile sulfur compounds in mouth air. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96(1):38–41. DOI: 10.1016/S1079-2104(03)00162-8.
  11. Outhouse TL, Al-Alawi R, Fedorowicz Z, et al. Tonguescraping for treating halitosis. Cochrane Database Syst Rev 2006;19(2):CD005519. DOI: 10.1002/14651858.CD005519.pub2.
  12. Scully C, Greenman J. Halitology (breath odour: aetiopathogenesis and management). Oral Dis 2012;18(4):333–345. DOI: 10.1111/j.1601-0825.2011.01890.x.
  13. Yaegaki KK, Sanada K. Biochemical and clinical factors influencing oral malodor in periodontal patients. J Periodontol 1992;63(9):783–789. DOI: 10.1902/jop.1992.63.9.783.
  14. Goldberg S, Cardash H, Browning H, et al. Isolation of Enterobacteriaceae from the mouth and potential association with malodor. J Dent Res 1977;6(11):1770–1775. DOI: 10.1177/00220345970760110801.
  15. Yaegaki K, Sanada K. Volatile sulfur compounds in mouth air from clinically healthy subjects and patients with periodontaldisease. J Periodontol Res 1992;27(4 Pt 1):233–238. DOI: 10.1111/j.1600-0765.1992.tb01673.x.
  16. Roldan S, Herrera D, O'Connor A, et al. A combined therapeutic approach to manage oral halitosis: a 3 month prospective case series. J Periodontol 2005;76(6):1025–1033. DOI: 10.1902/jop.2005.76. 6.1025.
  17. Bhat N, Bansal S, Thakur K, et al. Probiotics for oral health boon or bane. Res Pharm Health Sci 2018;4(2):448–453.
  18. Reid G, Jass J, Sebulsky MT, et al. Potential uses of probiotics in clinical practice. Clin Microbiol Rev 2003;16(4):658–672. DOI: 10.1128/CMR.16.4.658-672.2003.
  19. Saxelin M, Tynkkynen S, Mattila-Sandholm T, et al. Probiotic and other functional microbes: from markets to mechanisms. Curr Opin Biotechnol 2005;16(2):204–211. DOI: 10.1016/j.copbio.2005.02.003.
  20. Maukonen J, Mätto J, Suihko ML, et al. Intra-individual diversity and similarity of salivary and faecal microbiota. J Med Microbiol 2008;57(Pt 12):1560–1568. DOI: 10.1099/jmm.0.47352-0.
  21. Crociani F, Biavati B, Alessandrini A, et al. Bifidobacterium inopinatum sp. Nov. And Bifidobacterium denticolens sp. Nov., two new species isolated from human dental caries. Int J Syst Bacteriol 1996;46(2): 564–571. DOI: 10.1099/00207713-46-2-564.
  22. Beighton D, Gilbert SC, Clark D, et al. Isolation and identification of bifidobacteriaceae from human saliva. Appl Environ Microbiol 2008;74(20):6457–6460. DOI: 10.1128/AEM.00895-08.
  23. Agarwal E, Bajaj P, Guruprasad CN, et al. Probiotics: a novel step towards oral health. AOSR 2011;1(2):108–115.
  24. Geier MS, Butler RN, Howarth GS. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics. Int J Food Microbiol 2007;115:1–11. DOI: 10.1016/j.ijfoodmicro.2006.10.006.
  25. Roy D. Technological aspects related to the use of bifidobacteria in dairy products. Lait 2005;85:39–56. DOI: 10.1051/lait:2004026.
  26. Shah NP. Functional cultures and health benefits. Int Dairy J 2007;17:1262–1277. DOI: 10.1016/j.idairyj.2007.01.014.
  27. Haukioja A. Probiotics & oral health. Euro J Dent 2010;4(3):348–355. DOI: 10.1055/s-0039-1697851.
  28. Persson S, Edlund MB, Claesson R. The formation of hydrogen sulfide and methyl mercaptan by oral bacteria. Oral Microbiol Immunol 1990;5(4):195–201. DOI: 10.1111/j.1399-302X.1990.tb00645.x.
  29. Kazor CE, Mitchell PM, Lee AM, et al. Diversity of bacterial populations on the tongue dorsa of patients with halitosis & healthy patients. J Clin Microbiol 2003;41(2):558–565. DOI: 10.1128/jcm.41.2.558-563.2003.
  30. Burton JP, Chiclott CN, Tagg JR. The rationale & potential for the reduction of oral maladour using streptococcus salivarius probiotics. Oral diseases. 2005;11(Suppl 1):29–31. DOI: 10.1111/j.1601-0825.2005.01084.x.
  31. Suzuki N, Yoneda M, Tanake K, et al. Lactobacillus salivarius WB21-containing tablets for the treatment of oral malodor: a double-blind, randomized, placebo-controlled. Oral SurgOral Med Oral Pathol Oral Radiol 2014;117(4):462–470. DOI: 10.1016/j.oooo.2013.12.400.
  32. Caglar E, Kargul B, Tanboga I. Bacteriotherapy and probiotics’ role on oral health. Oral Dis 2005;11(3):131–137. DOI: 10.1111/j.1601-0825.2005.01109.x.
  33. Kang M-S, Kim B-G, Chung J, et al. Inhibitory effect of Weissella cibaria isolates on the production of volatile sulphur compounds. J Clin Periodontol 2006;33(3):226–232. DOI: 10.1111/j.1600-051X.2006.00893.x.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.